Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Chronic cerebral hypoperfusion induces post-stroke dementia following acute ischemic stroke in rats.

Back DB, Kwon KJ, Choi DH, Shin CY, Lee J, Han SH, Kim HY.

J Neuroinflammation. 2017 Nov 9;14(1):216. doi: 10.1186/s12974-017-0992-5.

2.

Systemic and Disease-Specific Risk Factors in Vascular Dementia: Diagnosis and Prevention.

Jaul E, Meiron O.

Front Aging Neurosci. 2017 Oct 17;9:333. doi: 10.3389/fnagi.2017.00333. eCollection 2017.

3.

Overweight, Obesity, and Survival After Stroke in the Framingham Heart Study.

Aparicio HJ, Himali JJ, Beiser AS, Davis-Plourde KL, Vasan RS, Kase CS, Wolf PA, Seshadri S.

J Am Heart Assoc. 2017 Jun 24;6(6). pii: e004721. doi: 10.1161/JAHA.116.004721.

4.

Sequence Analysis of Long-Term Readmissions among High-Impact Users of Cerebrovascular Patients.

Rao A, Bottle A, Darzi A, Aylin P.

Stroke Res Treat. 2017;2017:7062146. doi: 10.1155/2017/7062146. Epub 2017 May 16.

5.

STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.

Sachdev PS, Lo JW, Crawford JD, Mellon L, Hickey A, Williams D, Bordet R, Mendyk AM, Gelé P, Deplanque D, Bae HJ, Lim JS, Brodtmann A, Werden E, Cumming T, Köhler S, Verhey FR, Dong YH, Tan HH, Chen C, Xin X, Kalaria RN, Allan LM, Akinyemi RO, Ogunniyi A, Klimkowicz-Mrowiec A, Dichgans M, Wollenweber FA, Zietemann V, Hoffmann M, Desmond DW, Linden T, Blomstrand C, Fagerberg B, Skoog I, Godefroy O, Barbay M, Roussel M, Lee BC, Yu KH, Wardlaw J, Makin SJ, Doubal FN, Chappell FM, Srikanth VK, Thrift AG, Donnan GA, Kandiah N, Chander RJ, Lin X, Cordonnier C, Moulin S, Rossi C, Sabayan B, Stott DJ, Jukema JW, Melkas S, Jokinen H, Erkinjuntti T, Mok VC, Wong A, Lam BY, Leys D, Hénon H, Bombois S, Lipnicki DM, Kochan NA; STROKOG.

Alzheimers Dement (Amst). 2016 Nov 18;7:11-23. doi: 10.1016/j.dadm.2016.10.006. eCollection 2017.

6.

Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, Gulati M, Kamel H, Knopman DS, Launer LJ, Saczynski JS, Seshadri S, Zeki Al Hazzouri A; American Heart Association Council on Hypertension; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Stroke Council.

Hypertension. 2016 Dec;68(6):e67-e94. Epub 2016 Oct 10. Review.

7.

Atrial Fibrillation and Risk of Dementia/Cognitive Decline.

Shah AD, Merchant FM, Delurgio DB.

J Atr Fibrillation. 2016 Feb 29;8(5):1353. doi: 10.4022/jafib.1353. eCollection 2016 Feb-Mar. Review.

8.

Role of APOE ε4 Allele and Incident Stroke on Cognitive Decline and Mortality.

Rajan KB, Aggarwal NT, Schneider JA, Wilson RS, Everson-Rose SA, Evans DA.

Alzheimer Dis Assoc Disord. 2016 Oct-Dec;30(4):318-323.

9.

Hearing Impairment Affects Dementia Incidence. An Analysis Based on Longitudinal Health Claims Data in Germany.

Fritze T, Teipel S, Óvári A, Kilimann I, Witt G, Doblhammer G.

PLoS One. 2016 Jul 8;11(7):e0156876. doi: 10.1371/journal.pone.0156876. eCollection 2016.

10.

Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction.

Stoeckel LE, Arvanitakis Z, Gandy S, Small D, Kahn CR, Pascual-Leone A, Pawlyk A, Sherwin R, Smith P.

Version 2. F1000Res. 2016 Mar 15 [revised 2016 Jan 1];5:353. doi: 10.12688/f1000research.8300.2. eCollection 2016. Review.

11.

Antibodies to myelin basic protein are associated with cognitive decline after stroke.

Becker KJ, Tanzi P, Zierath D, Buckwalter MS.

J Neuroimmunol. 2016 Jun 15;295-296:9-11. doi: 10.1016/j.jneuroim.2016.04.001. Epub 2016 Apr 9.

12.

Vascular contributions to cognitive impairment.

Wright CB, Flores A.

Neurol Clin Pract. 2015 Jun;5(3):201-208.

13.

B-lymphocyte-mediated delayed cognitive impairment following stroke.

Doyle KP, Quach LN, Solé M, Axtell RC, Nguyen TV, Soler-Llavina GJ, Jurado S, Han J, Steinman L, Longo FM, Schneider JA, Malenka RC, Buckwalter MS.

J Neurosci. 2015 Feb 4;35(5):2133-45. doi: 10.1523/JNEUROSCI.4098-14.2015.

14.

Preventing Alzheimer's disease by means of natural selection.

Demetrius LA, Driver JA.

J R Soc Interface. 2015 Jan 6;12(102):20140919. Review.

15.

Cognitive performance after stroke--the Framingham Heart Study.

Weinstein G, Preis SR, Beiser AS, Au R, Kelly-Hayes M, Kase CS, Wolf PA, Seshadri S.

Int J Stroke. 2014 Oct;9 Suppl A100:48-54. doi: 10.1111/ijs.12275. Epub 2014 Apr 30.

16.

Post-stroke cognitive impairment: epidemiology, mechanisms and management.

Sun JH, Tan L, Yu JT.

Ann Transl Med. 2014 Aug;2(8):80. doi: 10.3978/j.issn.2305-5839.2014.08.05. Review.

17.

Cognitive state following stroke: the predominant role of preexisting white matter lesions.

Kliper E, Ben Assayag E, Tarrasch R, Artzi M, Korczyn AD, Shenhar-Tsarfaty S, Aizenstein O, Hallevi H, Mike A, Shopin L, Bornstein NM, Ben Bashat D.

PLoS One. 2014 Aug 25;9(8):e105461. doi: 10.1371/journal.pone.0105461. eCollection 2014.

18.

Prevalence of cognitive impairment no dementia in a rural area of Northern China.

Zhang Y, Shi Z, Liu M, Liu S, Yue W, Liu S, Xiang L, Lu H, Liu P, Wisniewski T, Wang J, Ji Y.

Neuroepidemiology. 2014;42(4):197-203. doi: 10.1159/000360138. Epub 2014 Apr 15.

19.

Changes in memory before and after stroke differ by age and sex, but not by race.

Wang Q, Mejía-Guevara I, Rist PM, Walter S, Capistrant BD, Glymour MM.

Cerebrovasc Dis. 2014;37(4):235-43. doi: 10.1159/000357557. Epub 2014 Mar 25.

20.

Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer's disease.

Liu H, Le W.

Transl Neurodegener. 2014 Mar 20;3(1):7. doi: 10.1186/2047-9158-3-7.

Supplemental Content

Support Center